- Quote, Chart, News
- Snapshot
- Company Report
- Quotes
- Charts
- Key Developments
Recent News- Research
- SEC Filings
- Advisor FYI
- CAPS
- StockScouter
- Earnings Estimates
- Analyst Ratings
- Financial Results
- Insider Trading
- Ownership
- Message Board
- Guided Research
- Research Wizard
- Find Stocks
- Stock Screener
- Stock Power Searches
- Top-Rated Stocks
- Related Links
- Quote Watchlist
- Expert Picks
- E-mail & Alerts
- IPO Center
- Message Boards
- Capital Gains Analysis
News resources
| LM Ericsson Telephone ADR Reptg 1 Ord Shs Class B (ERIC) | 4 stories... |
| Incyte Corp (INCY) | 3 stories... |
| Goldman Sachs Group Inc (GS) | 3 stories... |
| Nortel Networks Corp (NRTLQ) | 2 stories... |
| Microsoft Corp (MSFT) | 2 stories... |
| advertisement |
Wyeth: All Recent News
- 3 generations of Wyeths to be sold in NYC 11/24/2009
- NEW YORK (AP) - Three generations of Wyeth artworks will be auctioned next month, including 14 original oil canvases by N.C. Wyeth that were used to lavishly illustrate the classic adventure tale of "Robinson Crusoe."... Associated Press
- Zeroing In On What's Important 11/23/2009
- Pfizer's Amy Schulman on how she makes the most of every minute. At Forbes
- Moody's gives negative view on pharma credit 11/19/2009
- NEW YORK (AP) - Moody's Investors Service issued a negative opinion on the pharmaceutical industry Thursday, saying drugmaker credit ratings will be under pressure until early 2012 because they won't be able to fully replace revenue from best-sellers that go off-patent. Associated Press
- FDA panel backs Pfizer's enhanced vaccine for kids 11/18/2009
- BETHESDA, Md. (AP) - Federal health experts said Wednesday an updated version of Pfizer's best-selling anti-infection vaccine is safe and effective for infants and toddlers, despite company studies that failed to meet certain goals. Associated Press
- Vaccines on horizon for AIDS, Alzheimer's, herpes 11/18/2009
- MARIETTA, Pa. (AP) - Malaria. Tuberculosis. Alzheimer's disease. AIDS. Pandemic flu. Genital herpes. Urinary tract infections. Grass allergies. Traveler's diarrhea. You name it, the pharmaceutical industry is working on a vaccine to prevent it. Associated Press
- Pfizer move a new blow to Conn. city in land fight 11/16/2009
- NEW LONDON, Conn. (AP) - After drug giant Pfizer Inc. announced that it was opening a new research center here, city officials aggressively moved to acquire surrounding land for an economic development project — triggering an epic fight over eminent domain that reached the U.S. Supreme Court and ended with residents being forced from their homes. Associated Press
- Status of Pfizer and Wyeth research facilities 11/9/2009
- (AP) - Pfizer Inc., which just acquired fellow drugmaker Wyeth, is closing six of the two companies' research sites and keeping open 14 others. Two Cambridge, Mass., sites will operate as one. Following is a list of the sites:... Associated Press
- Pfizer trimming research plants after buying Wyeth 11/9/2009
- TRENTON, N.J. (AP) - Less than a month after buying Wyeth, drug giant Pfizer Inc. has mapped out a new structure for its research and development operations. Associated Press
- Moody's upgrades ratings for Wyeth 11/5/2009
- NEW YORK (AP) - Moody's Investors Service upgraded the senior unsecured ratings of Wyeth, citing the execution of an outstanding bonds agreement with Wyeth. Associated Press
- Merck, now No. 2 drugmaker, set for future buys 11/4/2009
- TRENTON, N.J. (AP) - The new Merck & Co. has become the world's second-biggest drugmaker overnight with a huge acquisition, but it still has a fat wallet and plans more wheeling and dealing. Associated Press
- New damages trial for Wyeth in Ark. hormones case 11/2/2009
- LITTLE ROCK, Ark. (AP) - Wyeth Pharmaceuticals will get a new trial to determine if the drugmaker should pay punitive damages to a woman who got breast cancer after taking hormone replacement therapy, a federal appeals court ruled Monday. Associated Press
- Pfizer giving 2 execs bonuses after Wyeth deal 10/28/2009
- NEW YORK (AP) - Pfizer Inc. said Wednesday it awarded bonuses of $1 million or more to two executives after completing its $68 billion purchase of former rival Wyeth. Associated Press
- Pa. jury returns verdict in Prempro-cancer case 10/26/2009
- PHILADELPHIA (AP) - A Philadelphia jury returned a sealed punitive-damages verdict Monday against drugmaker Wyeth Pharmaceuticals after finding a link between a woman's breast cancer and the hormone-replacement drug she took. Associated Press
- Earnings Preview: GlaxoSmithKline Q3 earns seen up 10/26/2009
- LONDON (AP) - GlaxoSmithKline PLC is expected to report higher third-quarter earnings before London's financial markets open Wednesday. The following is a summary of key developments and analyst opinion for the period. Associated Press
- Pfizer Completes Acquisition Of Wyeth 10/15/2009
- Pfizer (NYSE: PFE) and Wyeth (NYSE: WYE) announced today that Pfizer has completed its acquisition of Wyeth following the receipt of regulatory approval from all government authorities required by... Business Wire
- More News
- Market Report
- News by Symbol
- Today's Investing Articles
- Breaking News
- News by Topic
- News by Industry
- MSNBC News
- Data providers
- Copyright © 2009 Thomson Reuters. Click for Restrictions.
- Quotes supplied by Interactive Data Real-Time Services.